From January 1, 2024 to January 28, 2024, the company has repurchased 294,200 shares, representing 0.04% for CNY 1.65 million. With this, the company has completed the repurchase of 8,785,900 shares, representing 1.17% for CNY 50 million under the buyback announced on January 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.01 CNY | +0.20% | -1.38% | -9.40% |
1st Jan change | Capi. | |
---|---|---|
-9.40% | 486M | |
+18.33% | 42.25B | |
+15.37% | 21.27B | |
+19.55% | 15.23B | |
+20.08% | 14.36B | |
+52.09% | 12.74B | |
-0.05% | 6.79B | |
-12.40% | 6.61B | |
-8.87% | 5.73B | |
+14.28% | 5.66B |
- Stock Market
- Equities
- 603669 Stock
- News Lionco Pharmaceutical Group Co.,Ltd.
- Tranche Update on Lionco Pharmaceutical Group Co.,Ltd.'s Equity Buyback Plan announced on January 31, 2023.